Factors related to the mortality risk of severe hand, foot, and mouth ... - BMC Infectious Diseases

  • Huang CC, Liu CC, Chang YC, Yeh TF, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936–42. https://doi.org/10.1056/NEJM199909233411302.

    Article  CAS  PubMed  Google Scholar 

  • Xie YH, Chongsuvivatwong V, Tang Z, et al. Spatio-temporal clustering of hand, foot, and mouth disease at the county level in Guangxi, China. PLoS ONE. 2014;9(2):e88065. https://doi.org/10.1371/journal.pone.0088065.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen M, Ju Y, Chen M, et al. Epidemiological and genetic characteristics of EV71 in hand, foot, and mouth disease in Guangxi, southern China, from 2010 to 2015. PLoS ONE. 2017;12(12):e0188640. https://doi.org/10.1371/journal.pone.0188640.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chang LY, Lin HY, Gau SS, et al. Enterovirus A71 neurologic complications and long-term sequelae. J Biomed Sci. 2019;26(1):57. https://doi.org/10.1186/s12929-019-0552-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li YP, Liang ZL, Gao Q, et al. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, phase I clinical trial. Vaccine. 2012;30(22):3295–303. https://doi.org/10.1016/j.vaccine.2012.03.010.

    Article  CAS  PubMed  Google Scholar 

  • Li YP, Liang ZL, Xia JL, et al. Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial. J Infect Dis. 2014;209(1):46–55. https://doi.org/10.1093/infdis/jit429.

    Article  CAS  PubMed  Google Scholar 

  • Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818–28. https://doi.org/10.1056/NEJMoa1304923.

    Article  CAS  PubMed  Google Scholar 

  • Li R, Liu L, Mo Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829–37. https://doi.org/10.1056/NEJMoa1303224.

    Article  CAS  PubMed  Google Scholar 

  • Li JX, Song YF, Wang L, et al. Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children. Expert Rev Vaccines. 2016;15(1):129–37. https://doi.org/10.1586/14760584.2016.1096782.

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Jiang L, Zhang C, He W, Tan Y, Ning C. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine. 2021;39(25):3319–23. https://doi.org/10.1016/j.vaccine.2021.05.009.

    Article  CAS  PubMed  Google Scholar 

  • Ministry of Health of the People's Republic of China. Guide of diagnosis and Treatment for Hand, Foot, Mouth disease (2010 version). http://yzs.satcm.gov.cn/gongzuodongtai/2018-03-24/3073.html.

  • Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. Lancet Infect Dis. 2014;14(4):308–18. https://doi.org/10.1016/S1473-3099(13)70342-6.

    Article  PubMed  PubMed Central  Google Scholar 

  • The Ministry of Health of China. Guidelines for the Prevention and Control of Hand, Foot, and Mouth disease (2009 version). http://www.gov.cn/gzdt/2009-06/04/content_1332078.htm.

  • The Ministry of Health of China. Guidelines for the Prevention and Control of Hand, Foot, and Mouth disease (2008 version).http://www.gov.cn/yjgl/2008-05/03/content_960347.htm.

  • Peng D, Ma Y, Liu Y, Lv Q, Yin F. Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Sichuan Province, China, 2011–2017. Sci Rep. 2020;10(1):6117. https://doi.org/10.1038/s41598-020-63274-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun Z, Zhang G, Guo P, et al. Epidemiological characterizations, pathogen spectrum and molecular characteristics of Coxsackievirus A16 from patients with HFMD in Yantai, Shandong, China between 2011 and 2015. Hum Vaccin Immunother. 2017;13(8):1831–8. https://doi.org/10.1080/21645515.2017.1318233.

    Article  PubMed  PubMed Central  Google Scholar 

  • Huang J, Liao Q, Ooi MH, et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008–2015. Emerg Infect Dis. 2018;24(3):432–42. https://doi.org/10.3201/eid2403.171303.

    Article  PubMed  PubMed Central  Google Scholar 

  • Moosazadeh M, Abedi G, Afshari M, Kheradmand E, et al. Prevalence of enterobius vermicularis among children in Iran: a systematic review and meta-analysis. Osong Public. Health Res Perspect. 2017;8(2):108–15.

    Article  Google Scholar 

  • Jiang FC, Yang F, Chen L, et al. Meteorological factors affect the hand, foot, and mouth disease epidemic in Qingdao, China, 2007–2014. Epidemiol Infect. 2016;144(11):2354–62. https://doi.org/10.1017/S0950268816000601.

    Article  CAS  PubMed  Google Scholar 

  • Jiang L, Wang J, Zhang C, et al. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China. Vaccine. 2020;38(7):1804–9. https://doi.org/10.1016/j.vaccine.2019.12.025.

    Article  CAS  PubMed  Google Scholar 

  • Zhu J, Shi P, Zhou W, et al. Assessment of temperature-hand, foot, and mouth disease association and its variability across urban and rural populations in Wuxi, China: a distributed lag nonlinear analysis. Am J Trop Med Hyg. 2020;103(5):2091–9. https://doi.org/10.4269/ajtmh.20-0329.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang J, Hu T, Sun D, et al. Epidemiological characteristics of hand, foot, and mouth disease in Shandong, China, 2009–2016. Sci Rep. 2017;7(1):8900. https://doi.org/10.1038/s41598-017-09196-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ji H, Fan H, Ai J, et al. Neurocognitive deficits and sequelae following severe hand, foot, and mouth disease from 2009 to 2017, in JiangSu Province, China: a long-term follow-up study. Int J Infect Dis. 2022;115:245–55. https://doi.org/10.1016/j.ijid.2021.11.026.

    Article  PubMed  Google Scholar 

  • Liu H, Song G, He N, et al. Spatial-temporal variation and risk factor analysis of hand, foot, and mouth disease in children under 5 years old in Guangxi, China. BMC Public Health. 2019;19(1):1491. https://doi.org/10.1186/s12889-019-7619-y.

    Article  PubMed  PubMed Central  Google Scholar 

  • Xu C, Zhang X, Xiao G. Spatiotemporal decomposition and risk determinants of hand, foot and mouth disease in Henan. China Sci Total Environ. 2019;657:509–16. https://doi.org/10.1016/j.scitotenv.2018.12.039.

    Article  CAS  PubMed  Google Scholar 

  • Sun BJ, Chen HJ, Chen Y, et al. The risk factors of acquiring severe hand, foot, and mouth disease: a meta-analysis. Can J Infect Dis Med Microbiol. 2018;2018:2751457. https://doi.org/10.1155/2018/2751457.

    Article  PubMed  PubMed Central  Google Scholar 

  • Qiu J, Lu XL, Liu X, et al. Derivation and validation of a mortality risk score for severe hand, foot and mouth disease in China. Sci Rep. 2017;7(1):3371. https://doi.org/10.1155/2018/2751457.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tao J, He XY, Shi Y, et al. Epidemiology of 45,616 suspect cases of hand, foot and mouth disease in Chongqing, China, 2011–2015. Sci Rep. 2017;7:45630. https://doi.org/10.1038/srep45630.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Y, Zhou YH, Cheng YB, et al. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017–18: a test-negative case-control study. Lancet Child Adolesc Health. 2019;3(10):697–704. https://doi.org/10.1016/S2352-4642(19)30185-3.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang XL, An ZJ, Huo D, et al. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing. China Hum Vaccin Immunother. 2019;15(5):1183–90. https://doi.org/10.1080/21645515.2019.1581539.

    Article  PubMed  Google Scholar 

  • Du ZC, Huang Y, Bloom MS, et al. Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: a time-series analysis. Hum Vaccin Immunother. 2021;17(1):217–23. https://doi.org/10.1080/21645515.2020.1763076.

    Article  PubMed  Google Scholar 

  • Wang W, Song J, Wang J, et al. Cost-effectiveness of a national enterovirus 71 vaccination program in China. PLoS Negl Trop Dis. 2017;11(9):e0005899. https://doi.org/10.1371/journal.pntd.0005899.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jiang HC, Zhang Z, Rao Q, et al. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China. Emerg Microbes Infect. 2021;10(1):619–28. https://doi.org/10.1080/22221751.2021.1899772.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMoa2021436.

    Article  Google Scholar 

  • Garcia-Beltran WF, Lam EC, Astudillo MG, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184(2):476–88. https://doi.org/10.1016/j.cell.2020.12.015.

    Article  CAS  PubMed  Google Scholar 

  • Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–45. https://doi.org/10.1016/j.jinf.2020.03.019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Comments

    Popular posts from this blog

    Medical Review Board

    Top Doctors List 2021 | HOUR Detroit Magazine